Current:Home > NewsMerck sues U.S. government over plan to negotiate Medicare drug prices, claiming "extortion"-LoTradeCoin
Merck sues U.S. government over plan to negotiate Medicare drug prices, claiming "extortion"
View Date:2024-12-23 19:26:56
Drugmaker Merck is suing the U.S. government over its plan to allow Medicare to negotiate prices for a handful of drugs, calling it "extortion."
The plan, part of the 2022 Inflation Reduction Act, is expected to save taxpayers billions of dollars on common drugs the government pays for. The law directs the Center for Medicare and Medicaid Services to select 10 drugs with no generic or biosimilar equivalents to be subject to government price negotiation. (The list will eventually expand to 20 drugs.)
In its lawsuit, filed on Tuesday in federal court in the District of Columbia, Merck called the program "a sham" that "involves neither genuine 'negotiations' nor real 'agreements.'" Instead, the pharmaceutical firm said the U.S. Department of Health and Human Services selects drugs to be included and then dictates a discount, threatening drugmakers with "a ruinous daily excise tax" if they refuse the conditions.
Merck added that it expects its diabetes treatment, Januvia, to be subject to negotiation in the first round, with diabetes drug Janumet and the cancer drug Keytruda affected in later years.
The Rahway, New Jersey-based drugmaker is seeking to end the program. "It is tantamount to extortion," it said in the complaint.
Health and Human Services Secretary Xavier Becerra, who is named as a defendant in the suit, said in a statement that the agency plans to "vigorously defend" the drug price negotiation plan.
"The law is on our side," he said.
The lawsuit also names HHS and Chiquita Brooks-LaSure, administrator of the Centers for Medicare and Medicaid Services, as defendants.
Merck said the program violates elements of the Constitution, including the Fifth Amendment's requirement that the government pays "'just compensation' if it takes 'property' for public use," according to the complaint.
The drugmaker noted that Congress could have simply allowed HHS to state a maximum price it would pay for a drug, but that would have enabled drugmakers to walk away from talks, leaving millions of Medicare beneficiaries without essential medications, the complaint said.
Instead, Merck said the government uses the threat of severe penalties to requisition drugs and refuses to pay fair value, forcing drugmakers "to smile, play along, and pretend it is all part of a 'fair' and voluntary exchange." This violates the First Amendment, the suit claims, calling the process "political Kabuki theater."
Patient advocate slams Merck
David Mitchell, founder of the advocacy group "Patients For Affordable Drugs Now," slammed Merck's suit as an attempt to "unilaterally set prices that are untethered to quality at the expense of patients."
"The reality is, drug corporations that are subject to Medicare's new authority – and who already negotiate with every other high income country in the world – will engage in a negotiation process after setting their own launch prices and enjoying nine years or more of monopoly profits," Mitchell said in a statement.
He added, "Medicare negotiation is a desperately needed, long-awaited rebalancing of our drug price system that will help millions of patients obtain the medications they need at prices they can afford while ensuring continued innovation."
Medicare is the federally funded coverage program mainly for people who are age 65 and older. Currently, drug companies tell Medicare how much a prescription costs, leaving the federal government and Medicare beneficiaries to pay up.
The Inflation Reduction Act's drug negotiation provisions mark the first time that the federal government will bargain directly with drug companies over the price they charge for some of Medicare's costliest drugs. Government negotiation with drugmakers and price caps on drugs are common in other developed nations.
Republican lawmakers have also criticized President Joe Biden's administration over the drug pricing plan, saying it could deter drugmakers from developing new treatments.
The federal government is expected to soon release rules for negotiating drug prices. In September, it is scheduled to publish a list of 10 drugs that it will start price negotiations on next year. Negotiated prices won't take hold until 2026.
With reporting by the Associated Press.
- In:
- Medicare
- merck
veryGood! (23444)
Related
- 25 monkeys caught but more still missing after escape from research facility in SC
- Therapy dogs real stars of Women's College World Series, aiding mental health and performance
- New Jersey attorney general blames shore town for having too few police on boardwalk during melee
- Annapolis Pride Parade taking new route with 'Project Runway' winner Christian Siriano at head
- 24 more monkeys that escaped from a South Carolina lab are recovered unharmed
- University of the Arts abruptly announces June 7 closure, vows to help students transfer
- U.S. to make millions of bird flu vaccine doses this summer, as cases grow
- Florida deputy who fatally shot U.S. airman is fired following internal investigation
- Georgia lawmaker proposes new gun safety policies after school shooting
- From collapsed plea deal to trial: How Hunter Biden has come to face jurors on federal gun charges
Ranking
- Justice Department sues to block UnitedHealth Group’s $3.3 billion purchase of Amedisys
- The Daily Money: Dreaming online = dreamscrolling
- Robert Plant and Alison Krauss are equal parts ribbing and respect ahead of summer tour
- Olympic gold medalist Katie Ledecky says faith in anti-doping policies at 'all-time low'
- Bluesky has added 1 million users since the US election as people seek alternatives to X
- Swimmer Katie Ledecky on athlete doping scandals: I think our faith in some of the systems is at an all-time low
- Rainbow flag meaning: A brief history lesson on how the Pride flag came to be
- Malaysian climber who died in a cave near the top of North America’s tallest mountain is identified
Recommendation
-
Messi breaks silence on Inter Miami's playoff exit. What's next for his time in the US?
-
6-week-old baby fatally mauled in crib by family dog in Tennessee
-
From his Montana ranch, a retired lawmaker in a crowded House race is angling for a comeback
-
Biden addresses Trump verdict for first time
-
Too Hot to Handle’s Francesca Farago Gives Birth, Welcomes Twins With Jesse Sullivan
-
Pregnant Hailey Bieber Gives Shoutout to Baby Daddy Justin Bieber
-
Dance Moms Alum Kelly Hyland Reveals How Her Kids Are Supporting Her Through Cancer Treatments
-
Champions League final highlights: Real Madrid beats Dortmund to win 15th European crown